Vertex Reports Second-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
Vertex (VRTX) PT Raised to $203 at RBC Capital
July 26, 2018 8:44 AM EDTRBC Capital raised its price target on Vertex (NASDAQ: VRTX) to $203.00 (from $202.00) while maintaining an Outperform rating.
Analyst Brian Abrahams commented, "Despite rising expectations into 2Q, an impressive beat for VRTX's CF franchise."
... MoreVertex (VRTX) PT Raised to $204 at BMO Capital; 'Stellar Revenue'
July 26, 2018 7:11 AM EDTBMO Capital raised its price target on Vertex (NASDAQ: VRTX) to $204.00 (from $191.00) while maintaining an Outperform rating following results.
Analyst Do Kim commented, "We raise our revenue estimates and target price to $204 from $191, following stellar 2Q18 CF revenues that easily exceeded our and... More
Vertex (VRTX) PT Raised to $200 at Oppenheimer
July 26, 2018 6:59 AM EDTOppenheimer raised its price target on Vertex (NASDAQ: VRTX) to $200.00 (from $180.00) while maintaining an Outperform rating following results.
Analyst Hartaj Singh commented, "Vertex (VRTX) reported 2Q18 sales/earnings and provided a business update to investors on 7/25. Based on the company's robust results and... More
Vertex Pharma (VRTX) Tops Q2 EPS by 19c; Raises Outlook
July 25, 2018 4:03 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q2 EPS of $0.94, $0.19 better than the analyst estimate of $0.75. Revenue for the quarter came in at $750 million versus the consensus estimate of $680.98 million.
Company increases full-year 2018 total CF product revenue guidance to $2.9 to $3.0 billion; reiterates full-year 2018... More
